Aurinia Pharmaceuticals stock hits 52-week high at $16.72 By Investing.com
Aurinia Pharmaceuticals Inc. (AUPH) stock reached a 52-week high of $16.72, currently trading at $16.74, marking a 102.72% increase over the past year. The company boasts a market capitalization of $2.18 billion and a P/E ratio of 7.73, with InvestingPro suggesting it is undervalued with a fair value of $20.87. Recent positive developments include the acquisition of Kezar Life Sciences Inc. and strong financial results for Q4 2025, along with a new CEO appointment.
https://ca.investing.com/news/company-news/aurinia-pharmaceuticals-stock-hits-52week-high-at-1672-93CH-4583110